Moreover, altered DNA methylation of several genes has been associated with obesity, type II diabetes, and NASH [15–17, 32, 46, 47], but the role of FADS2 DNA methylation in NAFLD is unknown. The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatohepatitis.